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S u m m ar y  
 
Myeloid-derived suppressor cells (MDSCs) have been characteriz ed in cancer 
patients and tumor bearing mice based on their ability to suppress T-cell responses. 
Some recent studies also showed the impact of MDSC mediated immunomodulation 
during bacterial infections. However their role in infectious fungal diseases has not 
been described yet. Although, healthy individuals are also continuously exposed to 
fungi during their daily activities for example by inhaling fungal spores, they do not 
develop any pro-inflammatory anti-fungal immune responses. The underlying 
mechanisms for this tolerance are incompletely understood. W e hypothesiz ed that 
fungal infections induce MDSCs that modulate disease outcome.  
W e used a set of different methods that included in v itro  studies, in v iv o  mouse 
models, and human patients to demonstrate that the human-pathogenic fungi 
Aspergillus fumigatus and Candida albicans induce a distinct subset of neutrophilic 
myeloid-derived suppressor cells (MDSCs), which were able to functionally suppress. 
W e analyz ed the effect of the human-pathogenic fungi A. fumigatus and C. albicans 
on immune cells and noticed the expansion of a distinct cell population that was 
based on lineage markers and side-scatter granularity. Functionally, fungi-induced 
myeloid cells strongly suppressed CD4+ and CD8+ T cell proliferation in a dose-
dependent manner which defines MDSCs. In addition to regulating adaptive 
immunity, fungi-induced MDSCs also suppressed innate natural killer (NK ) cell 
responses. To assess whether fungi induce a similar cell population in v iv o , we 
q uantified MDSCs in healthy controls and patients with fungal infections and 
challenged mice with A. fumigatus or C. albicans. B oth approaches demonstrated 
that MDSCs accumulated in infected patients and mice. Fungi-induced MDSCs 
expressed neutrophilic markers in both human and mice (human: 
CD11b+CD66b+CD14-, mice: CD11b+Ly6G +) resembling neutrophilic MDSCs as 
described previously. Further in v itro  studies using blocking agents, immunodeficient 
patient samples and knockout mouse models showed that pathogenic fungi induced 
neutrophilic MDSCs through the pattern recognition receptor Dectin-1 and its 
downstream adaptor protein CARD9. W e further analyz ed the mechanism underlying 
fungal MDSC induction, and found that it was dependent on reactive oxygen species 
(ROS) production and involved Caspase-8 activity and interleukin-1. Furthermore, we 
used a murine model to assess the impact of MDSCs during systemic candidiasis 
and pulmonary aspergillosis in v iv o . After the adoptive transfer of bone marrow-
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derived neutrophilic MDSCs from healthy mice to the invasive C. albicans model, 
recipient mice showed better health conditions and increased survival rate. This 
protective effect of MDSCs was not present in A. fumigatus infection model.   
In summary, these studies uncover a new innate immune mechanism by which 
pathogenic fungi regulate host defence by inducing neutrophilic MDSCs, suggesting 
that this mechanism might play a broader and very important role in balancing 
inflammation during host-pathogen interactions. These findings also define a novel 
regulatory role of MDSCs during fungal infections, which might be clinically relevant 



























Z u sam m enfassu ng  
 
Myeloid-derived suppressor cells (MDSC) wurden in K rebspatienten und in 
Tumormausmodellen durch ihre Fä higkeit T-Zellantworten z u supprimieren 
beschrieben. Zudem konnten einige kü rz lich erschienene Studien z eigen, dass 
MDSCs auch wä hrend bakterieller Infektionen eine Rolle spielen. B isher wurde 
allerdings der E ffekt von MDSCs und ihren  Rolle wä hrend infektiö ser Pilz krankheiten 
noch nicht untersucht. E in Hinweis auf eine B eteiligung von MDSCs ist jedoch die 
B eobachtung, dass es immunkompetente Individuen gibt, die trotz  stä ndigem 
K ontakt mit Pilz en keine pro-inflammatorische Immunantwort z eigen, die gegen den 
Pilz  gerichtet ist. Dennoch sind die z ugrunde liegenden Mechanismen, die z u dieser 
Toleranz  fü hren, noch nicht vollstä ndig verstanden. Daher lautet unsere Hypothese, 
dass MDSCs wä hrend Pilz infektionen induz iert werden und dass diese wiederum 
den K rankheitsverlauf beeinflussen. 
Durch K ombination von in v itro  Studien, Mausmodellen und humanen Patienten, 
konnten wir z eigen, dass die human-pathogenen Pilz e Aspergillus fumigatus und 
Candida albicans einen U ntertyp von MDSCs - neutrophile MDSCs - induz ieren, 
welche in der Lage sind, T-Zellantworten z u unterdrü cken. Durch die U ntersuchung 
des E ffekts der humanpathogenen Pilz e A. fumigatus und C. albicans auf 
Immunz ellen konnten wir, basierend auf deren Zelltypmarker und G ranularitä t, die 
E xpansion einer besonderen Zellpopulation identifiz ieren. Diese Pilz -induz ierten 
MDSCs sind funktional und kö nnen daher CD4+ und CD8+ T-Zellproliferation 
dosisabhä ngig stark supprimieren, was ein Charakteristikum von MDSCs darstellt. 
Neben der Fä higkeit die adaptive Immunantwort z u regulieren, unterdrü cken Pilz -
induz ierte MDSCS auch natü rliche K illerz ellen (NK -Zellen), die einen Teil der 
angeborenen Immunantwort darstellen. U m z u untersuchen, ob Pilz e auch 
entsprechende Zellpopulation in v iv o  induz ieren kö nnen, wurden MDSCs in 
gesunden K ontrollindividuen sowie in Patienten mit Pilz infektionen q uantifiz iert. 
Zudem wurden Mä use mit Aspergillus intranasal oder mit C. albicans intravenö s 
infiz iert. B eide E xperimente z eigten, dass MDSCs in infiz ierten Patienten, wie auch in 
den infiz ierten Mä usen, erhö ht sind. Die pilz -induz ierten MDSCs exprimieren 
neutrophile Marker (human CD11b+CD66b+CD14-, maus: CD11b+Ly6G +), welche 
den neutrophilen MDSCs, wie vorher beschrieben, entspricht. Sowohl in den in v itro  
als auch den in v iv o  E xperimenten werden neutrophile MDSCs durch die pathogenen 
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Pilz e ü ber den Pattern-recognition Rez eptor Dectin-1 und dessen nachgeschaltetes 
Adaptorprotein CARD9 induz iert. Zudem ist die Induktion von MDSCs durch Pilz e 
abhä ngig von der Produktion von ROS, wie auch der Aktivitä t von Caspase-8 und 
Interleukin-1. Des weiteren wurde ein Mausmodell genutz t, um den E influss von 
MDSCs wä hrend einer systemischen Candidose und einer pulmonaren Aspergillen 
Infektion in v iv o  z u untersuchen. Nach dem adoptiven Transfer von neutrophilen 
MDSCs, die im K nochenmark generiert wurden, von gesunden W ildtyp-Mä usen z um 
invasiven C. albicans Model, z eigten dir E mpfä ngermä use eine bessere Fitnesst und 
eine hö here Ü berlebensrate. Dieser protektive E ffekt der MDSCs konnte im 
Infektionsmodell mit Aspergillus nicht gez eigt werden. 
Zusammenfassend wurde in dieser Studie ein neuer Mechanismus der angeborenen 
Immunantwort aufgedeckt, bei welchem pathogene Pilz e die Immunabwehr des W irts 
regulieren, indem sie neutrophile MDSCs induz ieren. Dies lä sst den Schluss z u, dass 
dieses Zusammenspiel eventuell eine sehr wichtige Rolle in der B alance der 
E ntz ü ndungsreaktion wä hrend der W irt-Pathogen Interaktionen spielt. Diese 
E rgebnisse geben MDSCs auch eine neue regulierende B edeutung im V erlauf von 
Pilz infektionen, was von klinischer Relevanz  in Hinsicht auf die E ntwicklung neuer 
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1 . Introd u ction 
 
1 .1  C a n d id a  a lb ic a n s  and  A s p e r g illu s  fu m ig a tu s : ’’Th e O p p or tu nistic,, fu ng al 
p ath og ens 
Candida albicans is a commensal diploid fungus of humans as well as other 
mammals and a part of the normal flora of human oral, gastrointestinal, vaginal and 
cutaneous surfaces (1). Almost about 80%  of healthy individuals are coloniz ed with 
C. albicans with no harmful effect. However when the host encounters an 
immunocompromised state such as prolonged antibiotic therapy, impaired immunity 
due to chemotherapy, or organ transplantation, C. albicans may turn highly 
pathogenic by invading tissues causing painful cutaneous or subcutaneous infections 
like vaginitis, oral thrush, diaper rash, conjunctivitis, and infections of the nail and 
rectum, or can even spread via blood stream to various body organs causing 
hepatosplenic abscesses, myocarditis or pulmonary infections, resulting in a fatal 
systemic candidiasis infection. It is generally believed that hyphal cells expressing 
cell-wall proteins that facilitate adhesion to human tissues are important for tissue 
invasion and escape from phagocytosis mediated by neutrophils or macrophages. On 
the other hand, the yeast form is known to be important for dissemination of the 
pathogen through the blood stream (Figure 1.1). Therefore, it is highly likely that the 
ability to switch between the morphological forms is very important for C. albicans 












Recently, Aspergillus fumigatus has been recogniz ed as the second most common 
causative agent of fungal infection after C. albicans.  In individuals with altered lung 
F ig u re 1 .1  C . a lb ic a n s  m or p h oty p es and  role in tissu e inv asion 
Adapted from G ow et al 2012 ©  Nature publishing group 
The several steps in tissue invasion by Candida albicans, for a styliz ed epthelial cell surface: adhesion 
to the epithelium; epithelial penetration and invasion by hyphae; vascular dissemination, which 
involves hyphal penetration of blood vessels and seeding of yeast cells into the bloodstream; and, 
finally, endothelial coloniz ation and penetration during disseminated disease. 
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function such as asthma and cystic fibrosis patients, A. fumigatus can cause allergic 
bronchopulmonary aspergillosis, a hypersensitive response to fungal components. 
Those most at risk for this life-threatening disease are individuals with hematological 
malignancies such as leukemia, solid-organ and hematopoietic stem cell transplant 
patients, patients on prolonged corticosteroid therapy, which is commonly utiliz ed for 
the prevention and/or treatment of graft-versus-host disease in transplant patients, 
individuals with genetic immunodeficiencies such as chronic granulomatous disease 
(CG D) (4). Mortality rates range from 40%  to 90%  in high-risk populations and are 
dependent on factors such as host immune status, the site of infection, and the 
treatment (5). B eing a saprophyte, A. fumigatus grows on soil and decaying organic 
debris where it produces conidia, that are disseminated by aerosoliz ation and inhaled 
in large numbers by all individuals (6). For A. fumigatus conidia to cause invasive 
aspergillosis, inhaled conidia must undergo the morphogenetic change like C. 
albicans. Major steps include germination of conidia, a process that involves mitosis 
and emergence of the initial germ tube. In order to continue growth and conseq uently 
invade the host tissue, the germ tubes must elongate by apical extension (Figure 
1.2). The result of this growth process results in long, tube-like hyphae, the 





F ig u re 1 .2  P ath og enesis of A . fu m ig a tu s  infections 
Adapted from B en-Ami et al 2010 ©  J ohn W iley &  Sons 
Pathogenesis of invasive aspergillosis in different immunological settings. (A) A. fumigatus conidia are 
inhaled by humans, and reach the terminal airways and pulmonary alveoli. (B ) In the alveoli, conidia 
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are destroyed by alveolar macrophages and polymorphonuclear leucocytes (PMNL). (C) In individuals 
with q uantitative or q ualitative defects in PMNLs, such as those who were exposed to cytotoxic drugs, 
A. fumigatus germination and tissue invasion proceed unabated. (D) Non-neutropenic hosts with a 
dysregulated immune response to A. fumigatus, for example patients receiving high dose 




1 .2  Im m u nity  to fu ng al infections 
1 .2 .1  R ecog nition of fu ng al p ath og ens by  p attern recog nition recep tors (P R R s) 
During recent years, tremendous advance studies have been conducted to broaden 
our knowledge of how immune system of the host responds towards fungal 
pathogens. E specially in terms of primary interaction between the pathogen and host, 
involvement of several pattern recognition receptor (PRR) pathways of fungal 
recognition and the type of T-cell responses have been shown. B eing the first line of 
interaction, the components of fungal cell wall are the most important factors to be 
recogniz ed by PRRs (1). The fungal cell wall is a highly complex structure which 
maintains the integrity and viability of fungal organisms. The main structural 
components of the fungal cell wall are -(1,3)-glucans, -(1,6)-glucans and chitin (a 
-(1,4)-polymer of N-acetylglucosamine (G lcNAc)) (Figure 1.3). These molecules are 







F ig u re 1 .3  F u ng al cell w all com p onents 
Adapted from Hardison and B rown 2012 ©  Nature publishing group 
E lectron micrograph of the fungal cell wall (C. albicans), with carbohydrate-rich layers of the fungal cell 
wall highlighted: mannan (mannosylated proteins), -glucan and chitin. Although it provides a rigid 
framework, which gives these pathogens their shape and protection from the environment, the cell wall 
is a dynamic structure that changes considerably, particularly during the morphological transitions that 
many fungi can undergo, for example yeast to hyphae. 
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The outer portion of the fungal cell wall is largely composed of mannan and 
mannoproteins, and the inner layer is composed of -(1,3)-glucan and chitin 
fragments. E xpression of various cell wall proteins and carbohydrates present on the 
cytoskeleton is significantly changed during fungal pathogenesis and morphogenetic 
development. This change mostly occurs during the transition from yeast form to 
hyphal form, which takes place when the fungus invades target organs of the host. In 
response, the host immune system, mediated by several PRRs can distiguish these 
fungal forms, in various ways that are beginning to be unraveled. 
Accumulating experimental evidence  from various research group demonstrates that 
PRR recognition by C. albicans in antigen presenting cells (APCs) results in secretion 
of various specific cytokines including IL-1, IL-23 and IL-6 (1, 9, 11). Furthermore it 
was found that, these cytokines promote skewing of activated CD4+ T cells into the 
Th17 lineage, which expresses IL-17 (also known as IL-17A), IL-17F and IL-22. It has 
also been shown that IL-17 and IL-17F are closely related cytokines that operate 
through a common receptor (composed of the IL-17RA and IL-17RC), and IL-17R 
signaling is very important for an effective anti-Candida immune response by the host 
(12).  
 
1 .2 .2  C -ty p e L ectin R ecep tors (C L R s) 
During past decade, the CLRs have been of very considerable attention in the 
context of antifungal immunity and appear to be comparatively more important than 
other PRRs in both mouse models of Candidiasis as well as in the humans (13, 14). 
CLRs are trans-membrane receptors which are expressed on, but not restricted to 
only myeloid cells including macrophages and dendritic cells. CLRs can also be 
found in abundance on lymphocytes, granulocytes, osteoclasts and epithelial cells of 
the host (15-17). The best-characteriz ed CLRs with respect to Candida are Dectin-1, 
Dectin-2 and Mincle (Figure 1.4). Although details of their respective signaling 
pathways are still being elucidated, they all appear to mediate signaling through the 





F ig u re 1 .4  C -ty p e L ectin R ecep tors in antifu ng al im m u nity  and  th eir  intracellu lar  sig naling  
p ath w ay s 
Adapted from Hardison and B rown 2012 ©  Nature publishing group 
Dectin-1, Dectin-2 and Mincle induce intracellular signaling via immunoreceptor tyrosine (Y )-based 
activation motifs, which recruit and activate Syk kinase either directly or indirectly through the FcR 
adaptor chain. Signaling through protein kinase C (PK C), this pathway activates the CARD9–B cl-10–
Malt1 complex, inducing gene transcription and the production of various inflammatory mediators. DC-
SIG N and Dectin-1 can signal via the Raf-1 kinase pathway, which modulates (dotted line) other 
signaling pathways, including those induced by the Toll-like receptor (TLR) and Syk pathways. The 
mannose receptor (MR) can also induce intracellular signaling, but the mechanisms involved are 
unknown. CLR signaling can collaborate with that of the TLR to synergistically induce or repress the 
induction of various cytokines and chemokines. 
 
 
1 .2 .3  D ectin-1  and  C A R D 9  
Dectin-1 is a well-defined CLR that recognises -1,3-glucans which are usually 
buried underneath a layer of cell wall proteins and mannan moieties, in the cell wall 
of Aspergillus, Candida and many other fungal species (15, 18-20). Nevertheless, -
glucan is exposed in bud scars that are revealed during the process of hyphal 
transition, which facilitates Candida recognition and may be the essential signal that 
alerts the host of a transition from fungal coloniz ation to infection (9). U pon ligand 
recognition, Dectin-1 signals through the Syk/CARD9 pathway via an ITAM-like motif 
(Figure 1.5). This motif is present in the intracellular signalling tail of Dectin-1 and 
uses a single phosphorylatable tyrosine residue to recruit Syk to dimerised Dectin-1 
(21). Recently, the kinase PK C was shown to be activated by Dectin-1 and induce 
phosphorylation of CARD9. B oth card9 -/- and pk c-/- mice are susceptible to 
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disseminated candidiasis (22, 23). These pathways induce cytokine and chemokine 
production including TNF, IL-2, IL-10, CX CL2 as well as IL-1, IL-6 and IL-23, key 
cytokines in the development of the antifungal Th17 response (14, 24). Dectin-1 also 
induces phagocytosis, respiratory burst and other antimicrobial effector mechanisms 
such as activation of the NLRP3 inflammasome via E RK -induced reactive oxygen 





F ig u re 1 .5  C A R D 9  in th e C -ty p e L ectin R ecep tor  sig naling  
Adapted from B lonska et al 2011 ©  Nature publishing group 
Activation of the Dectin-1 receptor by yeast-like, unicellular form of C. albicans or the Dectin-2 receptor 
by hyphal form of C. albicans leads to a seq uential activation of tyrosine kinase Syk, the CARD9-
B cl10-MALT1 complex and IK K . In this signaling cascade Syk mediates IK K  phosphorylation, whereas 
CARD9 controls NE MO polyubiq uitination. 
 
The importance of Dectin-1 in the control of fungal infections is highlighted by the 
susceptibility of Dectin-1-deficient mice to infection with C. albicans and A. fumigatus 
(27, 28). However, the role of Dectin-1 in fungal host defense remains a topic of 
debate. W hereas one study showed that dectin-1 -/- mice showed increased 
susceptibility to disseminated candidiasis (13, 20), another report found that dectin-1 -
/- mice were resistant. Intriguingly, in the study by Saijo et al., dectin-1 -/- mice were 
susceptible to P neumo cy stis carinii, suggesting that the role of Dectin-1 in antifungal 
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immunity may be pathogen-specific. Furthermore, Dectin-1 deficiency in humans can 
lead to susceptibility to certain fungal infections including chronic mucocutaneous 
candidiasis and recurrent vulvovaginal candidiasis (29). Predisposition to fungal 
infections can also be seen in CARD9-deficient humans. CARD9 deficiency has been 
studied in a family in which eight members were affected with a mutation causing a 
premature stop codon (Q 295X ), resulting in a truncated protein (30). 
In addition to promoting Th17 responses, Dectin-1 signaling appears to play a role in 
balancing the freq uencies of Th1 and Th17 cells. Specifically, the absence of dectin-
1 during lung infection with Aspergillus fumigatus causes reduced production of IFN 
and T-bet, a transcription factor that controls Th1 differentiation, resulting in 
decreased Th1 responses and correspondingly enhanced Th17 differentiation (31). 
Therefore, -glucan recognition by Dectin-1 shapes the overall nature of antifungal 
CD4+ T-cell helper responses. 
 
1 .2 .4  F u ng al infections and  th e inflam m asom e 
Inflammasone is defined as a large multiprotein complex that contains certain NOD-
like receptors, RIG I-like receptors and IFI200 proteins, the adaptor protein apoptosis-
associated speck-like protein containing a CARD (ASC; also known as PY CARD) 
and pro-caspase 1. Assembly of the inflammasome leads to the activation of 
Caspase 1, which cleaves pro-interleukin-1 (pro-IL-1) and pro-IL-18 to generate 
the active cytokines (11). Although neither of the cytosolic receptors NOD1 nor NOD2 
have been found to be req uired for Candida recognition (32), yet inflammasomes are 
involved. Previous studies have shown that mice deficient in the IL-1 receptor (IL-1R) 
or apoptosis-associated speck-like protein (ASC), an essential subunit of the 
inflammasome, exhibit increased oral fungal burdens in a model of oral mucosal 
candidiasis (33). Also, in this model, fungal dissemination was even more 
pronounced than mucosal infection. Consistent with these findings, nlrp3-/- mice are 
more susceptible to disseminated candidiasis as well as mucosal disease (34). 
Furthermore, sophisticated bone marrow chimera experiments validated the role of 
the NLRP3 inflammasome in preventing Candida dissemination, and further 
demonstrated important involvement of the NLRC4 inflammasome compartment  
during oral C. albicans host infections (35). It was noted that NLRP3 is req uired in 
hematopoietic cells, whereas NLRC4 functions at the level of the mucosal stroma. 
However, both NLRP3 and NLRC4 deficiencies resulted in decreased expression of 
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IL-17, IL-17F and also one of the IL-17 receptor subunits (IL-17RA), showing the 
direct interlink of the inflammasomes and IL-17 (35). Further work showed that bone 
marrow derived cells (B MDCs) from asc-/- and caspase-1 -/- mice exhibited impaired 
production of IL-1 and IL-18 following Candida exposure, which are important for 
Th17 and Th1 development, respectively.  
Along with these findings, splenocytes from IL-1 - and IL-18-deficient mice showed 
impaired production of IL-17 and IFN in response to Candida stimulation (36). 
Interestingly, the development of protective Th17 responses via inflammasome 
activation resulted from the recognition of C. albicans hyphae by human 
macrophages. On the other hand the yeast form did not activate the inflammasome, 
demonstrating that this pathway is likely important for discriminating between 
coloniz ing yeast forms and invasive hyphae of Candida (37). Recently, another 
member of the NLR family, NLRP10, was demonstrated to play an important role 
during host defense against disseminated candidiasis (38). NLRP10-mediated anti-
Candida immunity was shown to be dependent on induction of protective T cell 
responses, most likely Th1- and Th17- mediated as indicated by decreased IFN and 
IL-17 production from nlrp1 0 -/- splenocytes re-stimulated in v itro  with heat killed C. 
albicans cells. However, the absence of NLRP10 did not affect the production of IL-
1 by the host, indicating that C. albicans recognition by NLRP10 does not affect IL-






F ig u re 1 .6  A ctiv ation of th e noncanonical inflam m asom e 
Adapted from Dapaul-Chicoine et al 2012 ©  Nature publishing group 
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(a) In resting dendritic cells, caspase-8 is in complex with MALT1. A second pool of MALT1 interacts 
with B cl-10. After stimulation of dectin-1 with fungi or mycobacteria, engagement of Syk triggers 
activation of NF-B  and transcription of the gene encoding pro-IL-1 via the CARD9–B cl-10–MALT1 
complex. (b,c) A subset of pathogens, such as C. albicans (species CB S8781 and CB S8758), 
Candida tro picalis, Candida lusitaniae, Aspergillus fumigatus and M y co bacterium leprae, stimulate the 
production of bioactive IL-1 mainly via a noncanonical inflammasome composed of CARD9, B cl-10, 
MALT1, caspase-8 and ASC (b). Other pathogens, such as M y co bacterium tuberculo sis or 
M y co bacterium bo v is bacillus Calmette-G ué rin, engage both the classical NLRP3 inflammasome as 
well as the noncanonical caspase-8 inflammasome, leading to the secretion of IL-1 (c). 
 
In addition to the role of the NLRP3 and NLRC4 inflammasomes in processing pro-IL-
1, a recent study exhibited a Dectin-1-dependent activation of a non-canonical 
Caspase-8 inflammasome (40). Dectin-1 activation resulted in the activation of Syk 
followed by the transcription of the IL-1 gene through the CARD9-B cl10-MALT1 
complex. Recruitment of MALT1-caspase-8 and ASC to this scaffold resulted in 
processing of pro-IL-1 to mature IL-1 (Figure 1.6). Interestingly, the activation of 
this noncanonical pathway did not req uire C. albicans internaliz ation, unlike activation 
of the NLRP3 inflammasome that was completely dependent on internaliz ation. Since 
some C. albicans strains trigger IL-1 production primarily via Caspase-8 while 
others also activate the NLRP3 inflammasome, in can be suggested that the ligand 
for NLRP3 is not present in all fungi.  
Taken together, the priming of host-protective Th17 responses is likely a combined 
effort of multiple PRR pathways that recogniz e different components of pathogenic 
fungi, and triggers the production of cytokines that predominantly direct Th17 
differentiation. 
 
1 .3  M y eloid -d er iv ed  su p p ressor  cells  
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous cell population of 
immature monocytes and granulocytes that are potent inhibitors of T cell activation. 
In recent years, MDSCs have been classified as the cell population responsible for 
modulating immune responses (41, 42). The most important function of the MDSCs 
has been characteriz ed as to suppress T cells (43, 44). 
 
1 .3 .1  O r ig in and  ex p ansion of M D S C s 
In healthy individuals, immature myeloid cells (IMCs) normally reside in the bone 
marrow prior to their differentiation into mature granulocytes, macrophages, or 
dendritic cells. However, MDSCs are recruited into lymphoid and inflamed tissues 
during pathological and inflammatory conditions by the actions of various growth 
factors, such as G -CSF and G M-CSF, where alternations in cytokine homeostasis 
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state block their further differentiation into mature myeloid effector cells, and hence 




F ig u re 1 .7  Th e or ig in of M D S C s 
Adapted from G abrilovich et al 2009 ©  Nature publishing group 
Myelopoiesis of immature myeloid cells (IMCs) is controlled by soluble factors including G M-CSF, M-
CSF, SCF and IL-3. U nder healthy conditions, IMCs migrate to peripheral organs and differentiate into 
macrophages, DCs and granulocytes. Infection, trauma or tumor environment promote the 
accumulation of IMCs, prevent their differentiation and induce their activation to MDSC. 
 
Importantly, the activation of IMCs in pathological conditions results in the 
upregulation of their expression of immune suppressive factors, such as arginase 1 
(encoded by ARG 1) and inducible nitric oxide synthase (iNOS; also known as 
NOS2), as well as an increase in their production of NO (nitric oxide) and reactive 
oxygen species (ROS). This results in the expansion of an IMC population that has 
immune suppressive activity; these cells are now collectively known as MDSCs. In 
terms of infection and inflammation, the precise function of MDSCs and the 
mechanisms of MDSC induction are not well understood and are still under 
investigation. However some previous work showed that in a sepsis model with 
G ram-negative bacteria, their induction has been shown to be dependent on TLR4-
MyD88 activation (46). On the other hand in tumor models, different innate cytokines, 
such as IL-6, induce MDSC accumulation (47). It is also known that the suppression 
of IL-6 increases susceptibility to bacterial and fungal infections, indicating pleiotropic 
effects of IL-6 (48). 
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1 .3 .2  M ou se and  H u m an M D S C  su bsets: 
MDSCs are comprised of a phenotypically heterogeneous population of myeloid 
cells, which in mice are characteriz ed by the cóexpression of the myeloid cell 
differentiation antigen G r-1 and CD11b (M-integrin) (49, 50). In healthy mice, these 
cells comprise 20-30%  of total bone marrow cells, 2-4%  of splenocytes and are 
absent from the lymph nodes. Recently, two morphological and functional distinct 
MDSC subpopulations were described based on their expression of G r-1. The G r-1 
antigen includes the macrophage and neutrophil markers Ly6C and Ly6G , which can 
be separately detected by antibodies specific for their distinct epitopes. The Ly6 
family displays a group of low molecular weight molecules (12-20 kDa) that are 
phosphatidylinositol-anchored cell surface glycoproteins. Their triggering leads to a 
signal transduction resulting in T cell activation (51). U sing Ly6G  and Ly6C markers, 
two MDSC subsets were identified: CD11b+Ly6G +Ly6Clow MDSCs morphologically 
resembling polymorphonuclear granulocytes (G -MDSCs) and CD11b+Ly6G -Ly6Chigh 
MDSCs with monocytic phenotype (M-MDSCs) (52). Analysis of different tumor 
models showed that during tumor growth both subpopulations expanded, but in most 
cases the accumulation of G -MDSC was more prominent (53). Novel studies defined 
an additional subset according to the G r-1 staining intensities. CD11b+ splenocytes 
from different tumor models could be divided into G r-1high, G r-1int and G r-1low cells. 
G r-1high cells represented the G -MDSC subset, which exerted weak suppression on 
CD8+ T cells. W hile G r-1low cells resembled M-MDSCs with strong suppressive 
potential, the G r-1int subset displayed moderate suppression (54).   
In humans, MDSCs are most commonly defined as CD14-CD11b+ (G -MDSCs) and 
CD14+CD11b+ (M-MDSCs). E ven more narrowly, MDSCs are designated as cells 
that express the common myeloid marker CD33 but lack the expression of markers of 
mature myeloid and lymphoid cells, and of the MHC class II molecule human 
leucocyte antigen HLA-DR (2, 55). MDSCs have also been identified within a CD15+ 
population in human peripheral blood. In healthy individuals, IMCs constitute 0.5%  of 
peripheral blood mononuclear cells (2). Rodriguez  et al. proposed CD66b, a member 
of the carcinoembryonic antigen (CE A)-like glycoprotein family, as a marker for the 






F ig u re 1 .8  S u p p ressiv e m ech anism s m ed iated  by  d ifferent su bsets of M D S C s 
Adapted from G abrilovich et al 2009 ©  Nature publishing group 
In most tumour models, it is predominantly (70–80% ) the granulocytic subset of MDSCs that expands. 
G -MDSCs have increased activity of signal transducer and activator of transcription 3 (STAT3) and 
NADPH, which results in high levels of reactive oxygen species (ROS) but low nitric oxide (NO) 
production. ROS and, in particular, peroxynitrite (the product of a chemical reaction between 
superoxide anion and NO) induces the post-translational modification of T-cell receptors and may 
cause antigen-specific T-cell unresponsiveness. The M-MDSCs have upregulated expression of 
STAT1 and inducible nitric oxide synthase (iNOS), and increased levels of NO but low ROS 
production. NO, which is produced by the metabolism of L-arginine by iNOS, suppresses T-cell 
function through various different mechanisms that involve the inhibition of J anus kinase 3 and STAT5, 
the inhibition of MHC class II expression and the induction of T-cell apoptosis. B oth subsets have 
increased levels of arginase 1, which causes T-cell suppression through depletion of L-arginine. Only 
monocytic MDSCs can differentiate into mature dendritic cells and macrophages in v itro .  
 
 
1 .3 .3 . M D S C s in p ath olog ical cond itions 
Previous observations and most of the recent studies on the role of MDSCs in 
immune responses have been attributed to the cancer research. First 
characteriz ation of MDSCs was performed in tumour-bearing mice and in cancer 
patients. B ut growing evidence suggests that expansion and recruitment of MDSCs is 
a common feature of most pathological diseases. For instance, acute T ry pano so ma 
cruz i infection, which induces T-cell activation and increases the production of 
interferon- (IFN), also leads to the expansion of MDSCs (57, 58). A similar 
expansion of MDSCs has been reported during acute toxoplasmosis, polymicrobial 
sepsis, acute infection with L isteria mo no cy to genes, chronic infection with 
L eish mania majo r, infection with helminths  and very recently during S taph y lo co ccus 
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aureus infections (46, 59-62). E xpansion of MDSCs is also associated with 
autoimmunity and inflammation. In murine model of autoimmune encephalomyelitis, 
an increase in the number of MDSCs (specifically the CD11b+Ly6G –Ly6Chi monocytic 
subset) was observed in the spleen and blood (63). An immunosuppressive MDSC 
population was found to be increased in normal mice following immuniz ation with 
different antigens, including ovalbumin or peptide together with CFA, recombinant 





























2 . A im  of th e stu d y  
 
Due to transplantation-associated immunosuppression and the global impact of AIDS 
(Acq uired Immune Deficiency Syndrome), fungal diseases are on the rise. It has 
been shown that the anti-fungal immune response starts with an activation of the 
innate immune system, followed by adaptive T-cell responses but the underlying 
immune mechanisms are incompletely understood.  
The major aim of this work was to investigate how the pathogenic fungi interact with 
the immune system and modulate T-cell responses by inducing myeloid-derived 
suppressor cells (MDSCs). U sing various cellular in v itro , murine in v iv o  and patient 
studies we mimicked different immunological conditions of the host and screened 
how fungi induce myeloid-derived suppressor cells which functionally suppress T- 
and NK -cell responses. Furthermore, we analyz ed the mechanism behind fungal 
MDSC induction focussing on Dectin-1/CARD9 signalling, reactive oxygen species 
(ROS), caspase-8 activity and interleukin-1. In the next step, we also performed 
adoptive transfer and survival experiments to check the effects of MDSCs during 
systemic Candida albicans, and nasal Aspergillus fumigatus infection models in v iv o . 
B y this study, we expect to dissect a new mechanism by which fungi regulate T-cell 
immunity and exploit MDSCs to escape from host defence and to establish a bistable 
host-pathogen interaction, suggesting modulation of MDSCs as a novel therapeutic 















3 . D iscu ssion 
 
The central aim of this work was to investigate the role of myeloid-derived suppressor 
cells (MDSCs) in pathogenic fungal infections. W hile MDSCs have been 
characteriz ed thoroughly during various cancer related diseases, there is also a 
growing body of evidence that MDSCs play a key role in non-malignant conditions, 
particularly in chronic inflammation and infection (2, 65-71). However their phenotype 
and their functional relevance in infectious fungal diseases remain unknown. Our 
previous studies have shown that MDSCs play an important role in various 
pathologiocal conditions involving P seudo mo nas aerugino sa, cystic fibrosis and 
G vHD (G raft-versus-host disease) (71, 72). The present study has expanded the 
knowledge about immune suppressive effects of MDSCs to invasive life threatening 
fungal infections. U sing in v itro  assays, mouse models and patient studies, we 
demonstrate that a population of neutrophilic MDSCs accumulates during fungal 
infections and adoptive transfer of this population results in improved C. albicans 
clearance and survival of the mice. These findings suggest that MDSCs are one of 
the key contributors to the chronicity of C. albicans infection through their ability to 
modulate the host immune response.  
 
3 .1  P ath og enic fu ng i ind u ce m y eloid -d er iv ed  su p p ressor  cells (M D S C s) 
In this study, we show for the first time to our knowledge, the development of 
functional MDSCs in response to A. fumigatus and C. albicans infection in a set of 
subseq uent experimental models that included immunodeficient patients and in v iv o  
mouse infection models. This induced/expanded function of MDSCs was 
characteriz ed ex  v iv o  by strong and broad suppression of both T-cell and NK -cell 
responses as read out by various in v itro  proliferation and cytokine production 
assays. W ith the era of transplantation-associated immunosuppression and the 
global impact of AIDS, fungal infections are on the rise (8, 73-75) . Fungi are sensed 
through the innate immune system, which triggers effector cell recruitment to protect 
the host. E xcessive anti-fungal immune responses, however, cause tissue damage 
and impair fungal clearance. Protection of the host against fungi req uires a fine-tuned 
balance between pro-inflammatory effector and counter-regulatory mechanisms. 
Fungal infection induces an immunosuppressive state, and in murine models CD80+ 
neutrophilic cells have been shown to be importantly involved in this process (76). In 
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both, patients and mice, where MDSCs have been studied extensively, these cells 
comprise a granulocytic/neutrophilic (G -MDSCs) and a monocytic MDSC (M-MDSCs) 
subtype (77, 78). Recent data suggest that the neutrophilic/G -MDSC phenotype is 
the predominant one in humans. Functionally, fungi-induced myeloid cells strongly 
suppressed CD4+ and CD8+ T-cell proliferation in a dose-dependent manner, which 
defines MDSCs. In addition to regulating adaptive immunity, fungi-induced G -MDSCs 
suppressed innate natural killer NK -cell responses. 
 
3 .2  M D S C  ind u ction inv olv es D ectin-1 /C A R D 9 , R O S , casp ase-8 , and  IL -1  
Pathogenic fungi interact with a variety of host cells during the induction of disease. 
In order to cross the tissue barrier, for example during invasive aspergillosis, they 
normally invade nonphagocytic host cells such as epithelial and endothelial cells by 
triggering their own uptake. Infected epithelial cells play a key position participating in 
local airway inflammation via their production of cytokines and chemokines such as 
IL-6, IL-8, IL-1 and others that link the innate to the adaptive immune systems. 
Recent studies put the gut in the centre of immunotolerance. Dectin-1 was found to 
control colitis and intestinal Th17 responses through sensing of the fungal 
mycobiome (79). The immunological events downstream of Dectin-1 and their 
functional impact on Th17 cells remained elusive. Fungi-induced MDSCs expressed 
Dectin-1 at the cell surface, and blocking Dectin-1 diminished the MDSC-inducing 
effect. Dectin-1 receptor activation by the particulate ligands z ymosan and whole 
glucan particles (W G P), which operate through the phagocytic synapse, mimicked 
phenotypically and functionally the generation of MDSCs in vitro. Consistently, the 
potential of fungi or fungal patterns to induce neutrophilic MDSCs was diminished in 
human and murine Dectin-1 deficiency. To dissect Dectin-1 downstream signalling, 
we analysed the role of caspase recruitment domain 9 (CARD9), the key transducer 
of Dectin-1 signalling, in fungi-mediated MDSC generation in patients with genetic 
CARD9 deficiency and Card9 knock-out mice. These approaches demonstrated that 
CARD9 signalling was essential for fungal MDSC induction in humans and, to a 
lesser extent, in the murine system. Recent studies provided evidence that 
inflammasome-derived interleukin-1 beta (IL-1) and reactive oxygen species (ROS) 
are involved in MDSC and Th17 cell homeostasis. W e found an accumulation of 
intracellular IL-1 protein in CD33+ myeloid cells followed by a release of IL-1 into 
the cellular microenvironment upon Dectin-1 ligand- and fungal-driven MDSC 
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generation. Further studies, using chemical inhibitors and human patients with 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase deficiency (chronic 
granulomatous disease, CG D), demonstrated that ROS contributed substantially to 
fungal MDSC induction. Our results demonstrate that fungal Dectin-1/CARD9 
signaling induces MDSCs to dampen T-cell responses and suggest that the immune 
homeostasis in the gut could be modulated by fungal-induced MDSCs. B eyond fungi, 
the Dectin-1/CARD9 pathway has been involved in bacterial and viral infections (80), 
suggesting that this mechanism could play a broader role in balancing inflammation 
at host-pathogen interfaces. 
It has been previously reported that the complete genetic deletion of pro-
inflammatory cytokines, in particular TNF-, IL-1/ or IFN-, increases disease 
susceptibility in invasive fungal infections (1, 9, 37, 81, 82). On the other hand studies 
from other research groups tell that excessive inflammation causes collateral damage 
to the host (11, 83) indicating that efficient protection against fungi req uires a fine-
tuned balance between pro-inflammatory effector and counter-regulatory immune 
mechanisms. 
 
3 .3  A d op tiv e transfer  of M D S C s im p rov es su r v iv al in sy stem ic cand id iasis 
One notable finding in the present study was that mice infected with lethal dose of C. 
albicans exhibited improved survival after being adoptively transferred with MDSCs. 
Previously it has been shown that C. albicans and A. fumigatus pathogenesis differs 
substantially in terms of disease progression, T-cell dependency and organ 
manifestation (84). Our results that neutrophilic MDSCs were protective in a murine 
model of systemic C. albicans infection, but had no effect on pulmonary A. fumigatus 
infection underlines this disparity and suggests MDSCs as potential therapeutic 
approach in invasive C. albicans rather than A. fumigatus infections. The MDSC-
mediated effect was associated with downregulated NK - and T-cell activation and 
Th17 responses. It was further validated that supplementing Cytochalasin D and IL-
17A in v iv o  could, at least partially, dampen the protective effect of MDSCs. B ased 
on previous studies showing that NK  cells drive hyperinflammation in candidiasis in 
immunocompetent mice (85) and that IL-17 promotes fungal survival (86), we 
speculate that MDSCs in fungal infections could act beneficial for the host by 
dampening pathogenic hyperinflammatory NK  and Th17 responses (74, 75) 
Interestingly in amphibians, the fungus B atrach o ch y trium dendro batidis has recently 
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been shown to paralyz e lymphocyte responses, thereby dampening adaptive host 
defence (87), a mechanism reminiscent of MDSC activity, but the precise underlying 
factor mediating this effect remained elusive. B ased on our findings, we speculate 
that therapeutic modulation of MDSCs in fungal infections has the potential to tailor 
the host defence towards an effective elimination of the pathogen. Accordingly, 
enhancing neutrophilic MDSCs may present a novel anti-inflammatory treatment 
strategy for fungal infections, particularly with C. albicans. 
 
 
F ig u re 3 .1  P rop osed  m od el of M D S C  g eneration in inv asiv e fu ng al infections 
Adapted from Rieber et al 2015 ©  Cell Press 
Fungal sensing through Dectin-1 triggers downstream signaling cascades involving Syk and CARD9, 
leading to caspase-8 activation. Caspase-8 drives interleukin-1 (IL-1) production. Released IL-1 binds 
to the IL-1 receptor (IL-1R) and enhances generation of ROS, which are essential for MDSC induction. 
Moreover, ROS are involved in fungal-driven Caspase-8 activation. G enerated MDSCs inhibit NK  and 








3 .4  C onclu d ing  rem ar k s 
Our studies are just at the beginning to explore the role of MDSCs during pathogenic 
fungal infections. These data also highlight the importance of combining methods 
that include human and animal models, where C. albicans is a commensal and, as a 
result, the immune system is chronically exposed to the fungus. The fact that C. 
albicans is both a commensal and a pathogen (during the conditions of 
immunosuppression) adds an additional and intriguing level of complexity to the 
study of C. albicans-specific responses. To the best of our knowledge, this is the first 
study where the role of MDSCs in invasive fungal infections has been addressed. In 
light of these findings, we believe that induction of neutrophilic G -MDSCs and related 
factors are capable of regulating antifungal immune response of the host. G iven the 
well-known key role of this cell type in immune regulation, neutrophilic G -MDSCs 
may modulate the immunopathogenesis of infective fungal diseases and could 
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SUMMARY
Despite continuous contact with fungi, immuno-
competent individuals rarely develop pro-inflamma-
tory antifungal immune responses. The underlying
tolerogenic mechanisms are incompletely under-
stood. Using both mouse models and human
patients, we show that infection with the human
pathogenic fungi Aspergillus fumigatus and Candida
albicans induces a distinct subset of neutrophilic
myeloid-derived suppressor cells (MDSCs), which
functionally suppress T and NK cell responses.
Mechanistically, pathogenic fungi induce neutro-
philic MDSCs through the pattern recognition
receptor Dectin-1 and its downstream adaptor
protein CARD9. Fungal MDSC induction is further
dependent on pathways downstream of Dectin-1
signaling, notably reactive oxygen species (ROS)
generation as well as caspase-8 activity and
interleukin-1 (IL-1) production. Additionally, exoge-
nous IL-1b induces MDSCs to comparable levels
observed during C. albicans infection. Adoptive
transfer and survival experiments show that MDSCs
are protective during invasive C. albicans infection,
but not A. fumigatus infection. These studies define
an innate immune mechanism by which pathogenic
fungi regulate host defense.
INTRODUCTION
At mucosal sites, the human immune system is faced continu-
ously with microbes, rendering fine-tuned immune responses
essential to protect against pathogenic, while maintaining
tolerance against harmless, species. This immune balance is
of particular relevance for fungi, inhaled daily as spores or pre-
sent in the gut microflora as commensal yeasts (Romani, 2011).
While immunocompetent individuals do not develop invasive
fungal infections, infections are a major problem in patients
undergoing immunosuppression, for instance, at solid organ
or hematopoietic stem cell transplantation (Garcia-Vidal et al.,
2013).
Fungi are recognized through pattern recognition receptors,
mainly C-type lectin receptors (with Dectin-1 as the prototypic
one) (Steele et al., 2005), toll-like receptors (TLRs), and pen-
traxin 3 (PTX3) (Garlanda et al., 2002; Werner et al., 2009). A
certain level of inflammation is essential to control fungal infec-
tions (Brown, 2010), but hyperinflammatory responses seem to
cause more harm than good to the host. Particularly, Th17-
driven hyperinflammatory responses have been shown to
promote fungal growth (Zelante et al., 2012), to impair fungal
clearance, and to drive tissue damage (Romani et al., 2008;
Zelante et al., 2007). Generation of reactive oxygen species
(ROS), indoleamine 2,3-dioxygenase (IDO) activity, and activa-
tion of the TIR domain-containing adaptor-inducing interferon-b
(TRIF) pathway were found to limit hyperinflammatory re-
sponses toward Aspergillus fumigatus (Romani, 2011; Romani
et al., 2009). Yet, the cellular mechanisms by which fungi
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control T cell activation and maintain tolerogenic host-path-
ogen bistability remain incompletely understood.
Myeloid-derived suppressor cells (MDSCs) are innate immune
cells characterized by their capacity to suppress T cell re-
sponses (Gabrilovich and Nagaraj, 2009). MDSCs comprise a
neutrophilic and amonocytic subset. While the functional impact
of MDSCs in cancer is established, their role in host-pathogen
interactions is poorly defined. We hypothesized that fungal
infections induce MDSCs that modulate disease outcome.
RESULTS
We analyzed the effect of the human-pathogenic fungi
A. fumigatus andC. albicans on human immune cells and noticed
the appearance of a cell population that was different from
monocytes (CD14!), and expressed the myeloid markers
CD33+, CD11b+, CD16+, and CXCR4 (Figures 1A and S1A).
Fungi-induced myeloid cells strongly suppressed both CD4+
and CD8+ T cell proliferation in a dose-dependent manner
(Figure 1B), which defines MDSCs. Fungi-induced MDSCs also
suppressed innate natural killer (NK) cell responses, without
affecting cell survival (Figure S2). In contrast to growth factor-
induced MDSCs, fungi-induced MDSCs dampened Th2
responses, which play essential roles in fungal asthma (Kreindler
et al., 2010) (Figure S1B). We quantified MDSCs in patients
with invasive fungal infections and challenged mice with
A. fumigatus or C. albicans. MDSCs accumulated in both
A. fumigatus- and C. albicans-infected patients compared to
healthy and disease control patients without fungal infections
(Figure 1C). Murine studies further showed that systemic or pul-
monary fungal challenge with C. albicans (invasive disseminated
candidiasis) or A. fumigatus (pulmonary aspergillosis), as the
clinically relevant routes of infection, dose-dependently trig-
gered the recruitment of MDSCs in both immunocompetent
and immunosuppressed conditions, with a stronger MDSC
induction seen in immunocompetent animals (Figures 1D and
S1C). MDSCs expressed neutrophilic markers in both man and
mice, resembling the neutrophilic subtype of MDSCs (Rieber
et al., 2013), while monocytic MDSC subsets were not induced
(Figure S1D). Fungi-induced MDSCs functionally suppressed
T cell proliferation (Figure 1C), while autologous conventional
neutrophils failed to do (Figure S1E).
We adoptively transferred T cell-suppressive neutrophilic
MDSCs and monitored their impact on survival in fungal infec-
tion. While a single dose of adoptively transferred MDSCs was
protective in systemic C. albicans infection, MDSCs had no
impact on A. fumigatus infection (Figure 1E). Septic shock deter-
mines mortality in candidiasis (Spellberg et al., 2005), and the
interplay of fungal growth and renal immunopathology was
shown to correlate with host survival (Lionakis et al., 2011,
2013; Lionakis and Netea, 2013; Spellberg et al., 2003). Adop-
tively transferred MDSCs dampened renal T and NK cell activa-
tion and systemic Th17 and TNF-a cytokine responses (Figures
S1F and S1G). Conversely, supplementing IL-17A dampened
the MDSC-mediated protective effect (Figure 2A). Besides these
immunomodulatory effects, MDSCs might also act directly anti-
fungal, as our in vitro studies showed that they can phagocytose
and kill fungi (Figure 2B). However, direct antifungal effects could
hardly explain the beneficial effect of MDSCs in candidiasis: (i)
adoptively transferred MDSCs had no effect on fungal burden
in vivo (Figure 2A), (ii) inhibition of phagocytosis only partially
diminished the protection conferred by MDSCs (Figure 2A),
and (iii) MDSCs were exclusively protective in immunocompe-
tent mice (C. albicans infection model), with no effect in immuno-
suppressed (neutropenic) mice (A. fumigatus infection model).
The potency of A. fumigatus to induce MDSCs was most
pronounced for germ tubes and hyphae, morphotypes charac-
teristic for invasive fungal infections (Figure 1A) (Aimanianda
et al., 2009; Hohl et al., 2005; Moyes et al., 2010). The MDSC-
inducing fungal factor was present in conditioned supernatants
and was heat resistant (Figure 3A), pointing to b-glucans as the
bioactive component. We therefore focused on Dectin-1 as
b-glucan receptor and key fungal sensing system in myeloid
cells. Fungi-induced MDSCs expressed Dectin-1, and blocking
Dectin-1 prior to fungal exposure diminished the MDSC-
inducing effect, while blocking of TLR 4 had no effect (Figures
3B and S3). Furthermore, Dectin-1 receptor activation mimicked
the generation of neutrophilic MDSCs phenotypically and func-
tionally (Figures 3C and 3D). Dectin-1 receptor signaling was
confirmed by blocking of the spleen tyrosine kinase Syk, which
acts downstream of Dectin-1 (Figure 3B). We further used cells
from human genetic Dectin-1 deficiency and used Dectin-1
knockout mice for fungal infection models. The potential of fungi
or fungal patterns to induce neutrophilic MDSCs was diminished
in human and, albeit to a lesser extent, murine Dectin-1 defi-
ciency (Figures 3E and S1D). We analyzed the role of caspase
recruitment domain 9 (CARD9), a downstream adaptor protein
and key transducer of Dectin-1 signaling, in fungi-mediated
MDSC generation in patients with genetic CARD9 deficiency
and Card9 knockout mice. These approaches demonstrated
that CARD9 signaling was involved in fungal MDSC induction
in the human and the murine system (Figures 3E and 3F).
C. albicans induces interleukin-1 beta (IL-1b) in vitro (van de
Veerdonk et al., 2009) and in vivo (Hise et al., 2009), which is crit-
ical for antifungal immunity (Vonk et al., 2006). Recent studies
further provided evidence that IL-1b is involved inMDSC homeo-
stasis (Bruchard et al., 2013). We observed an accumulation of
intracellular IL-1b protein in CD33+ myeloid cells followed by
IL-1b release upon Dectin-1 ligand- and fungal-driven MDSC
induction (Figure 4A). IL-1b protein, in turn, was sufficient to drive
MDSC generation to a comparable extent asC. albicans did (Fig-
ure 4B). Studies in Il1r!/! mice, characterized by an increased
susceptibility toC. albicans infection, demonstrated that abroga-
tion of IL-1R signaling decreased MDSC accumulation in vivo
(Figures 4B and S4A), and IL-1R antagonism in patients with
autoinflammatory diseases decreased MDSCs (Figure S4B). As
the inflammasome is the major mechanism driving IL-1b gener-
ation in myeloid cells through caspase activities, we blocked
caspases chemically. We observed that pan-caspase inhibition
largely abolished fungi-induced MDSC generation, which was
not recapitulated by caspase-1 inhibition (Figure 4C). We there-
fore focused on caspase-8, since Dectin-1 activation was shown
to trigger IL-1b processing by a caspase-8-dependent mecha-
nism (Ganesan et al., 2014; Gringhuis et al., 2012). Indeed, fungal
MDSC induction was paralleled by a substantial increase of
caspase-8 activity, and caspase-8 inhibition diminished fungal-
induced IL-1b production (Figure 4C) and the potential of
fungi to induce MDSCs (Figure 4C). Conversely, supplementing




Figure 1. Fungi Induce Functional MDSCs In Vitro and In Vivo
(A) Fungal morphotypes differentially induce MDSCs.
Left panel: MDSCs were generated by incubating PBMCs (5 3 105/ml) from healthy donors with medium only (negative control), or different morphotypes of
A. fumigatus (conidia, 5 3 105/ml; germ tubes, 1 3 105/ml; hyphae, 1 3 105/ml) or C. albicans (yeasts, 1 3 105/ml; hyphae, 1 3 105/ml). The x-fold induction of
MDSCs compared to control conditions is depicted. *p < 0.05.
Right panel: representative histograms of fungi-induced MDSCs (CD11b+CD33+CD14!CD16+CXCR4+).
(B) Fungi-induced MDSCs suppress T cells. The suppressive effects of CD33+-MACS-isolated MDSCs were analyzed on CD4+ and CD8+ T cell proliferation.
MDSCs were generated by incubating PBMCs (53 105/ml) from healthy donors with A. fumigatus germ tubes (13 105/ml) or C. albicans yeasts (13 105/ml) for
6 days. Different MDSC-to-T cell ratios were assessed (1:2, 1:4, 1:6, 1:8, and 1:16). The lower bar graphs represent the proliferation index compared to control
conditions as means ± SEM.
(C) MDSCs in patients with fungal infections.
Left panel: MDSCswere characterized as CD14! cells expressing CD33, CD66b, CD16, CD11b, and CXCR4 in the PBMC fraction. The gray line shows unstained
controls. MDSCs were quantified in peripheral blood from healthy controls, immunosuppressed patients without fungal infections (disease controls, n = 5), or
immunosuppressed patients with invasive fungal infections (invasive A. fumigatus infections, n = 9, and invasive C. albicans infections, n = 6). *p < 0.05.
Right panel: representative CFSE stainings, showing the effect of MDSCs isolated (MACS) from patients with invasive A. fumigatus infections (left) or invasive
C. albicans infections (right) on CD4+ and CD8+ T cell proliferation.
(D) Fungi induce MDSCs in mice in vivo.
Upper left panel: C57/BL6 (n = 3mice per treatment group) or BALB/c (n = 4mice per treatment group) wild-typemice were not infected (white bars) or challenged
intranasally with 1 3 104 (light gray bar) or 1 3 106 (dark gray bar) A. fumigatus conidia for 3 days. On the fourth day, a bronchoalveolar lavage (BAL) was
performed, and CD11b+Ly6G+ MDSCs were quantified by FACS. The x-fold induction of CD11b+Ly6G+ MDSCs in the BAL compared to control non-infected
conditions is depicted. *p < 0.05.
Upper right panel: C57BL/6 mice were not infected (white bars) or injected via the lateral tail vein with 2.5 3 105 (light gray bar) or 5 3 105 (dark gray bar)
blastospores of C. albicans. On the fifth day, mice were sacrificed, and CD11b+Ly6G+ MDSCs in the spleen were quantified by FACS. The x-fold induction of
CD11b+Ly6G+ MDSCs in the spleen compared to control non-infected conditions is depicted. n = 5 mice per treatment group. *p < 0.05.
Lower panel: bonemarrow-isolated murine CD11b+Ly6G+MDSCswere co-cultured for 3 days with T cells (CD4+ splenocytes) at a 1:2 (MDSCs:T cell) ratio. T cell
proliferation was analyzed using the CFSE assay with and without MDSCs.
(E) Adoptive transfer of MDSCs modulates survival in fungal infection. For adoptive transfer experiments, CD11b+Ly6G+ MDSCs were isolated from the bone
marrow of BALB/c mice by MACS and checked for T cell suppression. In (A)–(D) bars represent means ± SEM.
Upper panel: adoptive MDSC transfer was performed by intravenous (i.v.) injection of 53 106MDSCs per animal. Sevenmice receivedMDSCs, while sevenmice
served as non-MDSC control animals. A total of 2 hr after the MDSC transfer, mice were i.v. injected with 13 105 blastospores ofC. albicans. Mice were weighed
daily and monitored for survival and signs of morbidity.
Lower panel: for invasive pulmonary A. fumigatus infection survival studies, mice were immunosuppressed by treatment with cyclophosphamide, and MDSC
transfer was performed by i.v. injection of 43 106MDSCs per animal. Five mice received MDSCs, while five mice served as non-MDSC control animals. After the
MDSC transfer, mice were challenged intranasally with 2 3 105 A. fumigatus conidia and were monitored for survival.
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IL-1b partially restored the abrogated MDSC generation upon
caspase-8 inhibition (Figure S4C).
ROS are key factors in MDSC homeostasis (Gabrilovich and
Nagaraj, 2009) and act downstream of Dectin-1 (Gross et al.,
2009; Underhill et al., 2005). Therefore, we tested the involve-
ment of ROS for fungal Dectin-1 ligand-induced MDSC genera-
tion using chemical inhibitors and cells from human CGD
patients with ROS deficiency. These studies demonstrated that
ROS contributed substantially to fungal MDSC induction (Fig-
ure 4D). Next, we investigated the interaction between ROS,
caspase-8, and IL-1b and found that ROS inhibition dampened
caspase-8 activity in response to fungi (Figure S4D). IL-1b, in
turn, induced ROS production during MDSC culture, suggesting
a positive feedback loop between caspase-8, IL-1b, and ROS in
MDSC generation (Figures S4E and S4F).
DISCUSSION
While the complete genetic deletion of pro-inflammatory cyto-
kines, particularly TNF-a, IL-1a/b, or IFN-g, increases disease
susceptibility in invasive fungal infections (Lionakis and Netea,
2013; Cheng et al., 2012; Gow et al., 2012; Netea et al., 2008,
2010), excessive inflammation causes collateral damage to the
host (Carvalho et al., 2012; Romani et al., 2008), indicating that
efficient protection against fungi requires a fine-tuned balance
between pro-inflammatory effector and counter-regulatory im-
mune mechanisms. Fungal infection induces an immunosup-
pressive state, and in murine models CD80+ neutrophilic cells
have been shown to be importantly involved in this process
(Mencacci et al., 2002; Romani, 2011; Romani et al., 1997). By
combining human and murine experimental systems, we extend
this concept by providing evidence for an MDSC-mediated
mechanism by which fungi modulate host defense, orchestrated
by Dectin-1/CARD9, ROS, caspase-8, and IL-1b. This effect
seems to be specific for neutrophilic MDSCs, since monocytic
MDSCs were unchanged under our experimental conditions
and were previously found to be downregulated by b-glucans
in tumor-bearing mice (Tian et al., 2013).
C. albicans and A. fumigatus infections differ substantially with
respect to T cell dependency and organ manifestation (Garcia-
Vidal et al., 2013). Our finding that neutrophilic MDSCswere pro-
tective in a murine model of systemic C. albicans infection, but
had no effect on pulmonary A. fumigatus infection, underlines
this disparity and suggests MDSCs as a potential therapeutic
approach in invasive C. albicans, rather than A. fumigatus infec-
tions. The MDSC-mediated effect was associated with down-
regulated NK and T cell activation, and Th17 responses and
supplementing IL-17A in vivo could, at least partially, dampen
the protective effect of MDSCs. Based on previous studies
showing that NK cells drive hyperinflammation in candidiasis in
immunocompetent mice (Quintin et al., 2014) and that IL-17 pro-
motes fungal survival (Zelante et al., 2012), we speculate that
MDSCs in fungal infections could act beneficial for the host
by dampening pathogenic hyperinflammatory NK and Th17 re-
sponses (Romani et al., 2008; Zelante et al., 2007). Accordingly,
enhancing neutrophilic MDSCsmay represent an anti-inflamma-
tory treatment strategy for fungal infections, particularly with
C. albicans.
Recent studies put the gut in the center of immunotolerance.
Dectin-1 was found to control colitis and intestinal Th17 re-
sponses through sensing of the fungal mycobiome (Iliev et al.,
2012). The immunological events downstream of Dectin-1 and
their functional impact on Th17 cells remained elusive. Our re-
sults demonstrate that fungal Dectin-1/CARD9 signaling induces
MDSCs todampenTcell responses andsuggest that the immune
homeostasis in the gut could be modulated by fungal-induced
A
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Figure 2. Antifungal Functions
(A) In vivo.
Left panel: survival in the invasive C. albicans
infection model after adoptive MDSC transfer.
Before adoptive transfer, isolated MDSCs were
pretreated with cytochalasin D (CytD, 1 mg/ml,
green line) or with recombinant mouse IL-17A
protein (5 mg/mouse, red line).
Right panel:C. albicansCFUs in kidneys of BALB/c
mice 5 days after adoptive transfer of MDSCs.
Bars represent means ± SD.
(B) In vitro.
Left panel: 1 3 106 human MDSCs were co-
cultured with 13 105 serum opsonized C. albicans
(10:1 ratio) for 3 hr at 37"C in RPMI. Serial dilutions
were performed of the cell suspension, and 100 ml
was plated onto YPD agar plates containing peni-
cillin and streptomycin. Plates were incubated for
24–48 hr at 37"C, and CFU were enumerated.
Middle and right panels: phagocytic capacity of
human and murine MDSCs. Middle panel; upper
(purple) FACS plots, isolated human granulocytic
MDSCs (low-density CD66b+CD33+ cells) were co-
cultured with or without GFP-labeled C. albicans
(CA) spores (MOI = 1) in RPMI medium at 37"C for
90 min. Lower (red) FACS plots, isolated mouse granulocytic CD11b+Ly6G+ MDSCs were co-cultured with or without GFP-labeled C. albicans spores (MOI = 4)
in RPMI medium at 37"C for 90 min. Representative dot blots are shown.
Right panel: GFP expression/fluorescence of MDSCs was analyzed by FACS and is given in the right panel as percentage of GFP+ MDSCs.
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MDSCs. Beyond fungi, the Dectin-1/CARD9 pathway has been
involved in bacterial and viral infections (Hsu et al., 2007),
suggesting that this mechanism could play a broader role in
balancing inflammation at host-pathogen interfaces.
EXPERIMENTAL PROCEDURES
Fungal Strains and Culture Conditions
A. fumigatus ATCC46645 conidia were incubated in RPMI at RT for 3 hr at
150 rpm to become swollen. Alternatively, conidia were cultured in RPMI over-
night at RT, followed by germination in RPMI either at 37"C for 3 hr at 150 rpm
to become germ tubes or at 37"C for 17 hr at 150 rpm to become hyphae.
C. albicans SC5314 was grown on SAB agar plates at 25"C. One colony
was inoculated and shaken at 200 rpm at 30"C in SAB broth overnight. To
generate hyphae, live yeast forms of C. albicans were grown for 6 hr at 37"C
in RPMI 1640. Killed yeasts and hyphae were prepared by heat treatment of
the cell suspension at 95"C for 45 min or by fixing the cells for 1 hr with 4%
paraformaldehyde followed by extensive washing with PBS to completely
remove the fixing agent. The C. albicans-GFP strain TG6 was pre-cultured at
30"C, 200 rpm overnight in YPD medium.
Generation, Isolation, and Characterization of MDSCs
Neutrophilic MDSCs in peripheral blood were quantified based on their lower
density and surface marker profiles as published previously (Rieber et al.,
2013). Human MDSCs were generated in vitro according to a published
protocol (Lechner et al., 2010). Murine MDSCs were characterized by
CD11b, Ly6G, and Ly6C. Flow cytometry was performed on a FACS Calibur
(BD Biosciences). Human and murine MDSCs were isolated using MACS
(MDSC Isolation Kit; Miltenyi Biotec).
T Cell Suppression Assays
T cell suppression assays were performed as described previously (Rieber
et al., 2013) using the CFSE method according to the manufacturer’s protocol
(Invitrogen).
Mouse Infection with A. fumigatus and C. albicans
Invasive C. albicans infection was established by IV injection in immunocom-
petent mice, whereas A. fumigatus infection was established by intranasal
challenge in immunosuppressed mice. CD11b+Ly6G+ and CD11b+Ly6C+
cells in the spleens, BAL, and kidneys were quantified by FACS. For adoptive
transfer experiments, CD11b+Ly6G+ MDSCs were isolated by MACS and
transferred by IV injection of 4 or 5 3 106 MDSCs per animal.
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Figure 3. Fungi Induce MDSCs through a Dectin-1-, Syk-, and CARD9-Mediated Mechanism
(A) Fungal factors mediating MDSC induction are heat resistant. MDSCs were generated by incubating PBMCs (5 3 105/ml) from healthy donors with medium
only (negative control), untreated, or heat-denatured (95"C, 30min) supernatants (SNT) ofA. fumigatus germ tubes (4%) for 6 days. The x-fold induction ofMDSCs
compared to control conditions is depicted. *p < 0.05 versus control conditions.
(B) Dectin-1 and Syk are involved in fungal MDSC induction. MDSCs were generated in vitro by incubating isolated PBMCs (5 3 105 cells/ml) with A. fumigatus
germ tubes (1 3 105/ml), hyphae (1 3 105/ml), and C. albicans yeasts (1 3 105/ml) for 6 days. Where indicated, PBMCs were pretreated for 60 min with anti-
Dectin-1 blocking antibody (15 mg/ml), soluble WGP (1 mg/ml), and a Syk inhibitor (100 nM). *p < 0.05 blocking versus unblocked conditions.
(C) Dectin-1/CARD9 ligands mimic fungal MDSC induction. MDSCs were generated in vitro by incubating isolated PBMCs with the Dectin-1/CARD9 ligands
zymosan depleted (10 mg/ml), dispersible WGP (20 mg/ml), or curdlan (10 mg/ml). p < 0.05 versus control conditions.
(D) Dectin-1/CARD9 ligands induce functional MDSCs. The suppressive effects of CD33+-MACS-isolated MDSCs were analyzed on CD4+ and CD8+ T cell
proliferation (CFSE polyclonal proliferation assay). MDSCs were generated by incubating PBMCs (5 3 105/ml) from healthy donors with zymosan depleted
(10 mg/ml) or dispersible WGP (20 mg/ml). MDSC, T cell ratio was 1:6.
(E) Fungal MDSC induction in patients with genetic Dectin-1 or CARD9 deficiency.
Left panel: MDSCswere generated in vitro by incubating isolated PBMCs (53 105 cells/ml) from healthy controls (n = 12), an individual with Dectin-1 deficiency, or
patients with CARD9 deficiency (n = 2) with the Dectin-1/CARD9 ligands zymosan depleted (10 mg/ml) or dispersible WGP (20 mg/ml).
Right panel: MDSCs were generated in vitro by incubating isolated PBMCs (53 105 cells/ml) from healthy controls (n = 12), an individual with genetically proven
Dectin-1 deficiency, or patients with CARD9 deficiency (n = 2) with different fungal morphotypes (1 3 105 cells/ml) for 6 days.
(F) CARD9 is involved in fungi-induced MDSC recruitment in vivo. Card9!/! mice and age-matched wild-type mice were challenged intranasally with 1 3 106
A. fumigatus conidia for 3 days. On the fourth day, a BAL was performed, and CD11b+Ly6G+ MDSCs were quantified by flow cytometry. In (B), (C), and (E) bars
represent means ± SEM.




Figure 4. Fungal MDSC Induction Involves IL-1b, Caspase-8, and ROS
(A) Intracellular accumulation and release of IL-1b.
Left panel: gating strategy for intracellular cytokine staining. IL-1b was analyzed in CD33+ myeloid cells using intracellular cytokine staining and flow cytometry.
Zymosan depleted (20, 100, and 500 mg/ml) and WGP dispersible (20, 100, and 500 mg/ml) were used for 1 hr to stimulate cytokine production.
Middle panel: leukocytes isolated from healthy donors (n = 4) were left untreated (empty circles) or were treated for 1 hr with increasing concentrations of
zymosan, WGP, A. fumigatus germ tubes, or C. albicans yeasts (each at 23 105/ml and 13 106/ml). IL-1b synthesis in CD33+ cells was analyzed by intracellular
cytokine stainings by flow cytometry. *p < 0.05 versus control/untreated conditions.
Right panel: co-culture supernatants were collected after incubating isolated PBMCs (5 3 105 cells/ml) with medium only (white bar), A. fumigatus germ tubes
(1 3 105 cells/ml), or C. albicans yeasts (1 3 105/ml) for 3 days. IL-1b was quantified by ELISA. *p < 0.05 versus medium control conditions.
(B) IL-1b signaling is involved in fungal-induced MDSC generation.
Left panel: MDSCs were generated in vitro by incubating isolated PBMCs (5 3 105 cells/ml) with C. albicans yeasts (1 3 105/ml) or recombinant human IL-1b
protein (0.01 mg/ml) for 6 days. *p < 0.05.
Right panel: MDSCs (CD11b+Ly6G+) were quantified in spleens from Il1r!/! and age-matched WT mice 2 days after i.v. infection with 1 3 105 blastospores of
C. albicans. *p < 0.05.
(C) Fungal MDSC generation involves caspase-8. MDSCs were generated in vitro by incubating isolated PBMCs (5 3 105 cells/ml) with C. albicans yeasts
(13 105/ml) for 6 days with or without pretreatment (where indicated) with the pan-caspase inhibitor Z-VAD-FMK (10 mM), the caspase-1 inhibitor Z-WEHD-FMK
(50 mM), or the caspase-8 inhibitor Z-IETD-FMK (50 mM). IL-1b protein levels were quantified in cell culture supernatants by ELISA (note: two values were below
detection limit). Caspase-8 activity was quantified in cell lysates using a luminescent assay. *p < 0.05.
(legend continued on next page)
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Abstract Patients with cystic fibrosis (CF) suffer from
chronic airway infection and inflammation. Traditionally,
bacteria have been regarded the main CF pathogens
while fungi have emerged and more recently warranted
greater attention. Fungi are increasingly found to colo-
nize CF airways; however, their precise clinical impact
continues to spark controversy. While the clinical rele-
vance of allergic bronchopulmonary aspergillosis
(ABPA) in CF has been established, the roles of non-
ABPA Aspergillus fumigatus, Candida albicans, and
other more rare emerging fungi remain poorly under-
stood. Here, we summarize and discuss recent findings
in this field and refer toward unresolved questions.
Keywords Cystic fibrosis . Fungi . Pathogens
Fungi in Cystic Fibrosis Lung Disease
Patients with cystic fibrosis (CF) suffer from chronic progres-
sive and infective lung disease, which determines morbidity
and mortality [1] . Upon disease progression, CF airways get
colonized with characteristic bacteria and fungi, mainly
P seud o m o nas aerugin o sa , S tap h y l o c o ccus aureus,
Aspergillus fumigatus, and Candida albicans. While the path-
ogenic role of bacteria, particularly P . aerugino sa, in CF lung
disease has been established, the contribution of emerging
pathogens [2] , such as fungi [3–5] , to the clinical course of
patients with CF lung disease remains incompletely under-
stood. Among fungi in CF, most evidence ex ists for
A. fumigatus. Chronic colonization with A. fumigatus can lead
to sensitization and, in 1–15 % of CF patients (depending on
the region, the patients’ age, and the diagnostic criteria), to a
severe clinical phenotype termed allergic bronchopulmonary
aspergillosis (ABPA). ABPA is a hypersensitivity reaction to
A. fumigatus characterized by a strong pro-allergic T helper
cell type 2 (Th2) immune response (increased total serum IgE
levels–typically > 1000 IU/ ml, skin prick tests positive,
A. fumigatus-specific IgE and IgG, precipitins to
A. fumigatus, sometimes eosinophilia) with pulmonary infil-
trates (typical: central bronchiectasis) and antibiotic-refractory
clinical deterioration, usually treated with antifungals (mostly
azols) and corticosteroids [6] . Besides ABPA, however, the
significance of non-ABPA A. fumigatus colonization and the
potential clinical impact of other fungi remain unclear [7] .
Fungi are predominantly found in adult CF patients and are
more prevalent in patients with preex isting severe pulmonary
disease and a long-term course of inhaled antibiotics [3] .
Several studies support the concept that fungi and
P . aerugino sa frequently co-ex ist in CF airways, supported
by a recent study showing that antibacterial treatments
targeted at P . aerugino sa reduce the A. fumigatus load in CF
airways [8••] . However, the interaction of fungi and bacteria is
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rather complex and involves synergistic as well as antagonis-
tic growth conditions, including biofilm formation and release
of tox ic metabolites [9, 10] . Despite studies, the overall clin-
ical relevance ofC. albicans and other more rare but emerging
fungi, such as S cedo spo rium spp., remains even more incom-
pletely ex amined. Faced with the increasing prevalence of
fungi in patients with CF lung disease, the challenges toward
the future remain to (i) define those fungi causing harm to the
host and differentiate them from innocent bystanders, (ii)
develop sensitive and specific biomarkers for diagnosis and
treatment monitoring, and (iii) evaluate specific antifungal and
anti-inflammatory therapeutic regimens and the contex ts in
which these are applicable. In the chapters below, we summa-
rize and discuss recent findings on fungi in CF, with a partic-
ular focus on studies contributing to the pathophysiological
understanding and clinical treatment in CF lung disease. For
more comprehensive and in-depth discussion of the field, we
refer to previously published reviews [3–5, 7, 11, 12] .
Recent Findings on Fungi in Cystic Fibrosis Lung Disease
Aspergillus
The airways of CF patients are frequently colonized with
Aspergillus species, but the disease relevance of this fungal
colonization pattern remains poorly understood. This is large-
ly due to the lack of an unified and harmonized immunolog-
ical classification of Aspergillus-associated disease pheno-
types in CF lung disease. Such a classification is hampered
by the fact that CF patients, beyond the severe but rare ABPA,
show awide range of immunological responses toAspergillus,
which require a more precise classification to define them and
to assess their clinical relevance. A recent study integrated two
novel methods of Aspergillus detection in airway fluids (spu-
tum), namely galactomannan (GM) and reverse transcription
polymerase chain reaction (RT-PCR) [13•• ] . Both new
methods were more sensitive in detecting Aspergillus species
in CF sputum samples compared to conventional culture-
based methodology. These two new Aspergillus markers in
combination with Aspergillus serology allowed the stratifica-
tion / classification of CF patients into three distinct
Aspergillus disease entities: (i) S ero lo gic AB P A: patients with
positive RT-PCR, positive GM, and elevated total and specific
A. fumigatus IgE/ IgG; (ii) Aspergillus bro nch itis: patients with
positive RT-PCR, positive GM, and elevatedA. fumigatus IgG
(not IgE); and (iii) Aspergillus sensitiz ed: patients with or
without positive RT-PCR, negative GM, and elevated
A. fumigatus IgE (not IgG). This novel classification may help
to identify and clinically follow-up different Aspergillus dis-
ease phenotypes in order to develop specific screening and
treatment approaches. However, sub-phenotypes probably
ex ist within these broader classifications groups, which will
require future studies to define.
Upon CF lung disease progression, both A. fumigatus
and P . aerugino sa are increasingly found in CF airway
fluids. However, the interaction between these two mi-
crobes in patients with CF lung disease is poorly un-
derstood, particularly the potential therapeutic implica-
tions if both pathogens are chronically detected in CF
sputa. A recent study assessed the effect of short-term
antipseudomonal intravenous antibiotics on the presence
of Aspergillus in CF airways in 26 adult CF patients
[8•• ] . This study showed that intravenous antibiotics
significantly decreased the presence of Aspergillus in
CF airways and improved lung function parameters,
suggesting that the presence of P . aerugino sa might
help Aspergillus to survive within the CF airway micro-
environment, maybe through mix ed biofilm formation,
and provides a rationale for intravenous antibiotic ther-
apy in patients with advanced CF lung disease and co-
colonization with P . aerugino sa and Aspergillus.
The more CF patients that undergo lung transplanta-
tion, the more the question arises, which bacteria or
fungi, found in CF airways prior to transplantation,
increase the risk for invasive infections afterwards.
This is of particular relevance for Aspergillus, as inva-
sive aspergillosis is a critical cause of mortality in
patients undergoing lung transplantation. In case of CF,
it remains unclear whether the colonization with
Aspergillus represents a risk factor for invasive asper-
gillosis post transplantation. A recent study addressed
this question by studying 93 CF patients before and
after lung transplantation with regard to their
Aspergillus colonization status using Aspergillus sputum
culture and bronchoalveolar lavage GM as Aspergillus
colonization markers [14•• ] . The study demonstrated
that 70 % of CF patients were colonized with
Aspergillus before undergoing lung transplantation and
22.5 % developed invasive aspergillosis with a mean
time of 42 days following transplantation. The related
1-year mortality was 16 % . In search of identifying
Aspergillus- associated risk and screening factors, the
authors further showed that particularly the positive
intraoperative detection of Aspergillus resulted in a four-
fold higher risk of developing invasive aspergillosis,
suggesting that this method could be used for early risk
assessment in CF patients undergoing lung transplanta-
tion. Moreover, the therapeutic implications of these
findings for potential prophylactic approaches in CF
patients scheduled for lung transplantation should be
further discussed.
Traditionally, ABPA is considered rare and mainly
found in older CF patients. Up to 15 % of CF patients
have been reported with ABPA and an even higher
Curr Fungal Infect Rep
percentage with subclinical disease. These notions, how-
ever, are based on different heterogenous reports and
lack broad high-quality epidemiological evidence.
Therefore, a recent study performed across countries
estimated the different manifestations of aspergillosis in
CF patients [15] . Incorporating various international CF
registries, this study confirmed the view that ABPA
prevalence substantially varies by country, probably
due to the current inadequate diagnostic ABPA criteria
and genetic influences. Moreover, this study implicates
an underdiagnosis of ABPA that occurs in children and
teenagers with an estimated rate < 1 % under 4 years
and increasing throughout childhood and adolescence.
When reviewed in combination, this study reinforces
the awareness to screen for ABPA and other
Aspergillus-related disease phenotypes (Aspergillus bron-
chitis and Aspergillus sensitization, see above) as early
as infancy to prevent disease progression into full-blown
ABPA.
Nevertheless, it remained a matter of debate in the CF field
whether Aspergillus colonization and/ or sensitization without
ABPA are associated with lung function declines. To address
this question, Bax ter and coworkers from the National
Aspergillosis Centre, University Hospital of South
Manchester, UK , performed a 2-year prospective observation-
al cohort study including 55 adult CF patients [16] . In this
cohort, 69 % showed airway colonization with Candida and
60 % with Aspergillus species. The authors did not find an
association between the presence of these fungi in CF
airways and lung function decline. However, patients sen-
sitized for Aspergillus species showed a greater lung func-
tion decline and an increase in their need for intravenous
antibiotics. Despite these intriguing findings, further studies
in larger and particularly younger CF cohorts are required
to dissect the relationship between fungal colonization,
sensitization and longitudinal lung function declines in
patients with CF.
Fungi Other Than Aspergillus
The clinical relevance of fungi other than Aspergillus, such as
Candida, S cedo spo rium, P seudallesch eria, P neumo cy stis
j iro v ecii, and P enicillium, remain poorly understood, but there
is an increasing number of studies analyzing these fungal
species in the contex t of CF lung disease. Accordingly, a
recent study found a high prevalence of a non-albicans
Candida species, namely C. dubliniensis, which was even
more prevalent than C. albicans in this CF study cohort
[17] .C. dubliniensiswas mainly detected in combination with
P . aerugino sa and S . aureus.
S ced o sp o rium species, mainly the S ced o sp o rium
apio spermum complex , are emerging and found in airway
fluids from older CF patients, but the clinical relevance of this
finding is debated. A recent study did not find an association
between sensitization against the S . apio spermum complex
and poorer lung function in patients with CF [18] . Further
studies are required to understand the potential role of this
fungus in CF lung disease.
Similar to S cedo spo rium, E x o ph iala dermatitidis is a fun-
gus that frequently colonizes the airways of CF patients with
an unclear clinical relevance. A recent study demonstrated that
E . dermatitidis was recovered in 17 % of CF patients, with
higher levels of IgG antibodies to E . dermatitidis in the
positive CF patients [19] . Interestingly, those patients were
more often colonized with non-tuberculous mycobacteria,
required more intravenous antibiotic treatment, and had a
lower lung function, suggesting that this fungus could have
a harmful impact on the course of CF lung disease.
A prospective multicenter study in France analyzed the
prevalence of P . j iro v ecii in 104 patients with CF lung disease
and found that it was present in 12.5 % of them [20] . In
contrast to other fungi, the presence of P . j iro v ecii was asso-
ciated with the absence of P . aerugino sa. Detection of
P . j iro v eciiwas associatedwith a greater lung function decline,
suggesting that this fungus could play an important, but hith-
erto underestimated, role in patients with CF lung disease. In
order to improve the methods of fungal detection, two studies
were recently published. Bernhardt and colleagues used
multilocus sequence typing (MLST) to characterize
S . apio spermum and P seudallesch eria bo y dii isolates from
CF patients [21] . Collectively, these studies demonstrated that
MLST technology is a highly effective tool for the study of
fungal colonization at an epidemiological level and to inves-
tigate whether fungal isolates are clonal or have undergone
recombination. These studies also showed that CF patients are
colonized by individual S . apio spermum and P . bo y dii strains
for up to a year-long period.
Masoud-Landgraf and coworkers compared different my-
cological culture methods to study fungi in CF sputum [22] .
These studies demonstrate that Candida albicans,
C. dubliniensis, and C. parapsilo sis were the most common
yeast species and Aspergillus fumigatus the most common
filamentous fungus, followed by S . apio spermum/ P . bo y dii
gro up and A. terreus. Longitudinal analyses also revealed that
fungal colonization patterns in CF patients are stable and
colonize the airways independent from antifungal treatments.
Methodologically, this study also showed that various fungal
species, particularly E . dermatitidis , R asams o nia
(G eo smith ia) argillacea, were isolated only from homoge-
nized sputum samples using mucolytics.
A significant number of CF patients suffer from ABPA
or “pre-ABPA” conditions. There is no doubt on the
indication to treat ABPA; however, there is still an ongo-
ing debate what treatment regimen should be chosen. Pre-
ABPA refers to non-defined clinical conditions of patients
not fulfilling all ABPA criteria, but showing disease
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deterioration associated with Aspergillus colonization and/
or sensitization without any further microbial or clinical
ex planation. In addition, other non-IgE mediated condi-
tions, such as Aspergillus bronchitis [23] , have been de-
scribed in CF patients. Due to the fact that Aspergillus is
the leading pathogen and the trigger of the above-
mentioned disease entities, a very interesting approach
seems to be the reduction of fungal load in the airways.
However, a recent placebo-controlled trial of antifungal
treatment in CF patients with A. fumigatus- positive spu-
tum reported a non-significant trend toward poorer lung
function in the patient group receiving itraconazole com-
pared with placebo [24• ] . These results were not only
attributed to the small study size (n = 35), but also due to
difficulties to achieve therapeutic itraconazole levels in
more than 40 % of the patients. The latter finding empha-
sizes the need for further clinical trials. In line with this,
other administration routes, e.g., inhalative azole therapy,
and alternative treatment options, such as anti-IgE
(omalizumab), should be evaluated in multicenter ap-
proaches. However, due to the dynamic shift between
the different disease entities, it will be difficult to define
inclusion criteria for these studies, but usage of enhanced
mycological techniques and modern biomarkers may help
to accurate clinical stratification into new classification
models.
Unresolved Questions
While maj or efforts have ex pended over the last decade in
understanding the role of fungi within the CF airways, signif-
icant unresolved questions remain. Although we have im-
proved our fungal detection and evaluation methodology, we
are not able to date to conclusively comment on their clinical
relevance [3] . Aspergillus, Candida, and S cedo spo rium spe-
cies have been the maj or focus of most work to date owing to
their isolation frequencies [4, 18, 25–27] . In order to deter-
mine the clinical effects of any particular fungi, investigations
into their virulence, pathogenesis, and signaling pathways are
imperative.
& A maj or challenge for CF clinicians looking toward
the literature for insight on the field is the cross-
sectional nature of many clinical studies making it
hard to establish causality for episodes of clinical
deterioration. As a consequence, a maj or unanswered
clinical question is that of treatment: when, why, and
how? A genuine need for investment in prospective
placebo-controlled trials to evaluate antifungal thera-
pies in a wide range of clinical settings is now
therefore j ustifiable. This would begin to address
the key and largest question in the field to date:
what is the clinical significance of the fungi detected
in CF samples and when and if treatment is indicat-
ed. Of course, the outcomes will vary dependent
upon the fungi, CF clinical status, and the individ-
ual’s response to infection.
& When and by what mechanism are fungi pathogenic? The
current literature is littered with controversies and debate
within this field. Do they establish infection early in
infancy or later in disease? Do they cause harm initially
or over time? Does synergism ex ist? What is the relevance
of the clinical setting or fungal virulence? Should they be
treated and if so what agents and for what duration? All
such questions are relevant but lack data to answer effec-
tively at present.
& Significant differences in isolation and identification
techniques ex ist internationally between mycology
laboratories resulting in some misidentification of cer-
tain fungi [3, 28] . This has been reported in the liter-
ature and impacts on our understanding of the “real”
incidence of colonization and infection in CF popula-
tions. Additionally, it is likely that there is an under-
estimation of both importance and significance of
fungi in CF. The increasing use and focus on
molecular-based detection techniques and genotyping
for fungi in CF represent a maj or step forward in
standardization, and further important questions re-
main with regard to the diagnosis and use of bio-
markers in ABPA [29] . The new immunological clas-
sifications described in this review will continue to be
refined allowing the identification of sub-phenotypes
of fungal “colonizers” previously unrecognized that
are likely at risk of clinical deterioration [13•• ] .
& Host-derived factors, including the state of the immune
system, severity of CF disease, effect of inflammation, and
the burden of treatment, all play critical roles in determin-
ing susceptibility, while fungal type, virulence, genotype,
and immunoevasive capabilities all too have their place
[30] . It is this combination of host and pathogen-related
factors that determines if a particular fungus at a certain
point in time will represent a colonizer or pathogen within
the CF lung.
Recent findings provide new insights into (i) the
relevance of fungal colonization and sensitization in
CF beyond ABPA, (ii) the clinical impact of the inter-
action between fungi and bacteria, and (iii) the potential
role of rare fungi for the outcome of CF lung disease.
Looking into the future, our focus should remain on
both developing methodology to accurately detect and
attempting clinical trials to eradicate in an effort to
provide an evidence base for treatment as and when it
may be required.
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A. B. C. 
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CXCR4+ neutrophils (%) in sputum 
SpearmanÔs rho coefficient !: 
 -0.349; P=0.027 
  C. 
Figure 3. 
Aspergillus +: rho=-0.734; P<0.01 






























CXCR4+  neutrophils (%)  
in peripheral blood 
SpearmanÔs rho coefficient !: 
 -0.04; P=0.8 
   A.   B. 

























































































































CXCR4! neutrophils (%) in sputum 
 
SpearmanÔs rho coefficient !: 
0.554; P=0.002 
A. B. Figure 4. 
SpearmanÔs rho coefficient !: 
0.158; P=0.404 
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